A small clinical trial demonstrated significant symptomatic improvement in patients with treatment-resistant depression and suicidal ideation following radiosurgical treatment of a brain pathway. Thirteen of fourteen patients with suicidal ideation experienced resolution of this symptom, and the average BDI score decreased by more than half across eighteen evaluable patients.
Eleven patients showed a fifty percent or greater reduction in their BDI score. Most patients, twenty in total, experienced some degree of improvement from baseline. The treatment effect was sustained for at least one year in most patients. No patient exhibited neurologic deficits, cognitive decline, personality changes, or signs of hemorrhage or infection.
The study involved patients with a median age of 60 and an average symptom duration of 33 years, many of whom had proven refractory to transcranial magnetic stimulation, electroconvulsive therapy, and ketamine. Cognitive function, as assessed by the Montreal Cognitive Assessment, remained stable. This approach, stereotactic radiosurgical capsulotomy, has been previously studied in the setting of severe obsessive-compulsive disorder. Further studies, including sham-controlled, randomized trials incorporating functional imaging, are planned.